Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Vaccines

Free Subscription 08.06.2026 1 AIDS 1 Ann Intern Med 2 BMJ 2 Clin Infect Dis 4 J Infect Dis 1 J Virol 1 JAMA 2 Nat Immunol 2 Nat Med 1 Pediatr Infect Dis J 3 PLoS One 12 Vaccine 1 Virus Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AIDS

1. MOUSSAOU ME, Ladang A, Maes N, Cavalie E, et al
   Heterogeneity of baseline immune activation and SARS-CoV-2 vaccine responses in people with HIV: a multicenter prospective study.
   AIDS. 2026 Jun 2. doi: 10.1097/QAD.0000000000004557.
   PubMed         Abstract available
   
   

   
   Ann Intern Med

2. CENTOR RM, Lee RA
   Annals On Call - Who Should Receive the RSV Vaccine?
   Ann Intern Med. 2026 Jun 2:e2602379OC. doi: 10.7326/ANNALS-26-02379.
   PubMed        
   
   

   
   BMJ

3. BARANIUK C
   Ebola: Three vaccines rushed into development for Bundibugyo outbreak.
   BMJ. 2026;393:e557985.
   PubMed        
   
   
4. WILLIAMS S
   Six ways Gavi will continue to immunise half the world's children amid vaccine backlash and a funding crisis.
   BMJ. 2026;393:e393658.
   PubMed        
   
   

   
   Clin Infect Dis

5. BONTEN M, Essink B, Hanning N, Leroux-Roels I, et al
   Immunogenicity and safety of co-administration of AS01E-adjuvanted respiratory syncytial virus prefusion F protein vaccine and a COVID-19 mRNA vaccine in adults aged >/=50 years: a phase 3, randomized, non-inferiority trial.
   Clin Infect Dis. 2026 Jun 4:ciag344. doi: 10.1093.
   PubMed         Abstract available
   
   
6. LIU C, Okoli GN, Chen R, Sullivan SG, et al
   SARS-CoV-2 vaccination and attenuation of breakthrough infection severity: A systematic global review and meta-analysis.
   Clin Infect Dis. 2026 Jun 1:ciag346. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   J Infect Dis

7. FREYN AW, Budigi Y, Girard B, Santos G, et al
   Cell-Mediated Immunity of mRNA-1283 Vaccine Encoding SARS-CoV-2 Spike Receptor-Binding and N-Terminal Domains in Preclinical and Clinical Studies.
   J Infect Dis. 2026 Jun 4:jiag248. doi: 10.1093.
   PubMed         Abstract available
   
   
8. CARDUCCI M, Sarakinou E, Massai L, Rovetini L, et al
   Immunogenicity of a Bivalent Typhoid-Paratyphoid Conjugate Vaccine Against Diverse Salmonella Paratyphi A Isolates.
   J Infect Dis. 2026 Jun 3:jiag275. doi: 10.1093.
   PubMed         Abstract available
   
   
9. GODDARD K, Ellingson MK, Brewer NT
   How to Fight for Immunization When Vaccine Skeptics Are Calling the Shots.
   J Infect Dis. 2026 Jun 3:jiag252. doi: 10.1093.
   PubMed        
   
   
10. FREEDMAN DO
    Chikungunya Vaccines for Travelers: Unanswered Pragmatic Questions Persist.
    J Infect Dis. 2026 May 30:jiag284. doi: 10.1093.
    PubMed        
    
    

    
    J Virol

11. WANG L, Shen J
    Progress in enterovirus D68-neutralizing antibodies and vaccines.
    J Virol. 2026 Jun 3:e0012326. doi: 10.1128/jvi.00123.
    PubMed         Abstract available
    
    

    
    JAMA

12. JENG WJ, Yip TC, Lok AS
    Hepatitis B: A Review.
    JAMA. 2026 May 4. doi: 10.1001/jama.2026.6070.
    PubMed         Abstract available
    
    

    
    Nat Immunol

13. KELCHTERMANS L, Geerts K, Pham CT, Malviya V, et al
    CD4(+) T cell-mediated immunity protects from VSV-SUD lethal challenge in a mouse model of Sudan virus infection.
    Nat Immunol. 2026;27:1224-1236.
    PubMed         Abstract available
    
    
14. SARAIVA M, Branchett WJ, Rengarajan J, O'Garra A, et al
    The host immune response to Mycobacterium tuberculosis determining protection or disease progression.
    Nat Immunol. 2026;27:1104-1118.
    PubMed         Abstract available
    
    

    
    Nat Med

15. DE JONG SPJ, Russell CA
    Limited evidence of AI superiority in seasonal influenza vaccine strain selection.
    Nat Med. 2026 Jun 3. doi: 10.1038/s41591-026-04461.
    PubMed        
    
    
16. SHI W, Wohlwend J, Wu M, Barzilay R, et al
    Reply to: Limited evidence of AI superiority in seasonal influenza vaccine strain selection.
    Nat Med. 2026 Jun 3. doi: 10.1038/s41591-026-04460.
    PubMed        
    
    

    
    Pediatr Infect Dis J

17. KRIEG V, Nickson N, Eberly MD, Manaloor J, et al
    A Case Series of Vaccine-strain Reactivation Varicella Zoster in Two Pediatric Patients Presenting With Headache and Rash.
    Pediatr Infect Dis J. 2026 Jun 3. doi: 10.1097/INF.0000000000005300.
    PubMed         Abstract available
    
    

    
    PLoS One

18. ODEBUNMI OO, Ilyasova A, Bamogo A, Patel Y, et al
    Exploring primary care health professionals' perceived influence of their communication on HPV vaccine acceptance: Results from a national survey.
    PLoS One. 2026;21:e0350507.
    PubMed         Abstract available
    
    
19. AKELLO LM, Osuret J, Galiwango J, Mwaka AD, et al
    Hepatitis B vaccine uptake and associated factors among pregnant women attending antenatal care at Gulu Regional Referral Hospital, Northern Uganda.
    PLoS One. 2026;21:e0350568.
    PubMed         Abstract available
    
    
20. ANACONA GPV, Correa ACG, Narvaez-Cuenca CE, Vasquez TM, et al
    Exploring the genetic architecture underlying dietary fiber content in Colombian Andean blueberry (Vaccinium meridionale Swartz).
    PLoS One. 2026;21:e0344321.
    PubMed         Abstract available
    
    

    
    Vaccine

21. NOUHI A, Abolmaali S, Darvish Alipour Astaneh S
    XcpQ from Pseudomonas aeruginosa: A potential vaccine candidate with immunogenic properties in zebrafish.
    Vaccine. 2026;87:128768.
    PubMed         Abstract available
    
    
22. SHARMA A, Kerkhoff AD, Haambokoma M, Shamoya B, et al
    Corrigendum to "Intention to receive new vaccines post-COVID-19 pandemic among adults and health workers in Lusaka, Zambia" ["Vaccine 50 (2025) 126846].
    Vaccine. 2026 May 31:128757. doi: 10.1016/j.vaccine.2026.128757.
    PubMed        
    
    
23. DAS S, Tenaglia BM, Riley D, Speed S, et al
    BECC-adjuvanted hemagglutinin influenza vaccine promotes enhanced immunogenicity and protective efficacy.
    Vaccine. 2026;87:128774.
    PubMed         Abstract available
    
    
24. VOLPI CR, Chama J, Adebiyi R, Aigoro JA, et al
    Understanding HPV vaccine preferences among sexual minority men living with HIV in Abuja, Nigeria using a discrete choice experiment.
    Vaccine. 2026;87:128771.
    PubMed         Abstract available
    
    
25. LI Y, Dong X, Yang A, Yu X, et al
    Development and efficacy evaluation of an inactivated Bordetella bronchiseptica vaccine in cats.
    Vaccine. 2026;87:128778.
    PubMed         Abstract available
    
    
26. EIDEN AL, Zheng Y, Wang D, Frew PM, et al
    Changes in attitudes and beliefs about childhood vaccination among parents in the United States: A repeat cross-sectional survey before and after the COVID-19 pandemic.
    Vaccine. 2026;87:128760.
    PubMed         Abstract available
    
    
27. DIVANI M, Katsanaki A, Poulianiti C, Lykotsetas E, et al
    Lipid peroxidation marker malondialdehyde is an independent determinant of hepatitis B vaccine response in hemodialysis patients.
    Vaccine. 2026;87:128776.
    PubMed         Abstract available
    
    
28. DELLA CIOPPA G, Sahai N, Dodeur V, Dutton JL, et al
    Safety, immunogenicity, and dose ranging of a bivalent respiratory syncytial virus and human metapneumovirus glycoprotein F-molecular clamp vaccine candidate in older adults: 1-month interim analysis of an ongoing randomised, observer-blind, placebo-
    Vaccine. 2026;87:128772.
    PubMed         Abstract available
    
    
29. LE TOURNEAU N, Sharma A, Pry JM, Haambokoma M, et al
    Corrigendum to "Drivers of decision-making for future adult vaccines: a best-worst scaling among community members and health care workers in Zambia" [Vaccine 70 (2026) 128003].
    Vaccine. 2026;87:128756.
    PubMed        
    
    
30. MARIN-CABA E, Lorusso N, Sempere J, Jimenez-Moleon JJ, et al
    Young adults at risk of emerging serotype 4 invasive pneumococcal disease vs. other serotypes in Andalusia (Spain), 2022 to 2024: optimising conjugated vaccines strategies.
    Vaccine. 2026;88:128790.
    PubMed         Abstract available
    
    
31. CARAZO S, Skowronski DM, Sauvageau C, Talbot D, et al
    2024/25 end-of-season KP.2 vaccine effectiveness against COVID-19 hospitalization in older adults: a test-negative study in Quebec, Canada.
    Vaccine. 2026;88:128786.
    PubMed         Abstract available
    
    
32. MOROS A, Deulofeu M, Ribo M, Bosch-Rue E, et al
    Multiple monovalent COVID-19 PHH-1V vaccine adaptations elicit homologous and cross-neutralizing antibody responses in mice.
    Vaccine. 2026;87:128781.
    PubMed         Abstract available
    
    

    
    Virus Res

33. SEDAGHAT M, Najafi F, Khosravi Shademani F, Rezaeian S, et al
    Seasonal influenza vaccine and frequency of adverse events in health workers receiving two doses of AstraZeneca vaccine: a retrospective cohort study.
    Virus Res. 2026;369:199757.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum